Robaxin vs. Soma
See how Robaxin and Soma compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Robaxin (methocarbamol) is not a controlled substance, while Soma (carisoprodol) is a Schedule IV drug with abuse and dependence risk.
Both drugs treat short-term discomfort from acute musculoskeletal injuries, and neither is approved for long-term or chronic pain.
Robaxin comes in oral and injectable forms, while Soma is only available as an oral tablet and is limited to 2 to 3 weeks of use.
Robaxin vs. Soma Drug Summary
Robaxin
Robaxin (methocarbamol) is a centrally-acting skeletal muscle relaxant used alongside rest and physical therapy for acute musculoskeletal pain. It comes as an oral tablet or an IV/IM injection, with the injectable form also used as adjunct therapy for tetanus. Robaxin has been available since 1957 and is not a federally controlled substance.
Soma
Soma (carisoprodol) is a skeletal muscle relaxant used short-term for discomfort from acute musculoskeletal conditions in adults. It is taken as an oral tablet three times daily plus a bedtime dose, for no more than 2 to 3 weeks. Soma is a Schedule IV controlled substance due to its potential for misuse and dependence.
Robaxin vs. Soma Side Effects
Robaxin
Soma
Robaxin vs. Soma Dosage
Robaxin
Soma
| STAGE | DOSE | WHEN |
| Starting dose | 1500 mg four times daily | Days 1-3 |
| Maximum dose | 1000 mg IM/IV per dose | If needed |
| Dose changes | 2 increases | Every 3 days |
| STAGE | DOSE | WHEN |
| Starting dose | 250 mg to 350 mg TID + HS | At the start |
| Maximum dose | 250 mg to 350 mg TID + HS | Same as starting |
| Dose changes | None | Fixed dose |
Robaxin
| STAGE | DOSE | WHEN |
| Starting dose | 1500 mg four times daily | Days 1-3 |
| Maximum dose | 1000 mg IM/IV per dose | If needed |
| Dose changes | 2 increases | Every 3 days |
Soma
| STAGE | DOSE | WHEN |
| Starting dose | 250 mg to 350 mg TID + HS | At the start |
| Maximum dose | 250 mg to 350 mg TID + HS | Same as starting |
| Dose changes | None | Fixed dose |
Robaxin vs. Soma Indications
Robaxin
Robaxin is FDA-approved as an adjunct to rest and physical therapy for relief of discomfort from acute, painful musculoskeletal conditions. The injectable form is also used as adjunctive therapy in tetanus management. It is not approved for chronic pain or for children under 16.
Adjunct to rest and physical therapy for acute muscle pain
Adjunctive therapy in tetanus (injectable form only)
Not approved for chronic or long-term pain management
Not approved for patients under 16 years old
Soma
Soma is FDA-approved for short-term relief of discomfort from acute, painful musculoskeletal conditions in adults. It is intended for use of no more than 2 to 3 weeks, since longer-term efficacy hasn't been established. Soma is not approved for children or for chronic musculoskeletal pain.
Short-term relief of acute musculoskeletal pain in adults
Limited to 2 to 3 weeks of use
Not approved for chronic pain conditions
Not approved for pediatric patients
Robaxin vs. Soma Pros and Cons
Robaxin
Robaxin offers a non-controlled option for short-term muscle pain relief, with both oral and injectable forms available for different care settings. Its exact side effect rates aren't detailed in the label, but reported reactions are typical for this drug class. It has a long track record of use dating back to 1957.
Pros
Not a controlled substance, so lower abuse/dependence risk
Available as both oral tablets and IV/IM injection
Can be used for tetanus adjunct therapy in hospital settings
Cons
Exact side effect rates aren't specified in FDA labeling
Requires frequent dosing, up to four times daily, during titration
Injectable form can cause tissue injury if given improperly
Not studied or approved for chronic pain use
Soma
Soma provides effective short-term muscle relaxation but carries a Schedule IV controlled substance designation because of its misuse potential. Its use is restricted to 2 to 3 weeks since longer-term benefit and safety haven't been established. Its active metabolite, meprobamate, adds to its sedative and dependence-related risks.
Pros
Simple fixed dosing schedule, three times daily plus bedtime
Well-documented short-term efficacy for acute muscle pain
Oral-only tablet, no injectable administration needed
Cons
Schedule IV controlled substance with misuse and diversion risk
Risk of withdrawal symptoms if stopped abruptly after prolonged use
Limited to 2 to 3 weeks, unsuitable for ongoing pain
Active metabolite meprobamate is itself a controlled sedative
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.